Clinical Trial Update: Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating circulating tumor DNA–guided intensification of postoperative therapy in resected colon cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Stage II Colon Cancer, Stage III Colon Cancer | Phase 2 | Status: SUSPENDED